Literature DB >> 12645684

At issue: management of medication noncompliance in schizophrenia by families in India.

Tirupati N Srinivasan1, Rangaswamy Thara.   

Abstract

Noncompliance with medication during a symptomatic phase is a common problem in the treatment of schizophrenia patients. In India, a majority of patients live with their families and those families supervise patients' medication intake. In a study of patients attending an urban outpatient care center in India, it was noted that when the patients were acutely ill and refused to take medication, the families administered medication to them without patients' knowledge, under the supervision of the psychiatrist. This method had been practiced by families in half the cases of patient noncompliance. Many families felt that there was no other viable alternative under the circumstances. Only a minority of patients was aware of having received medication through this method, and many of them reacted negatively to it. However, the patients were subsequently taking treatment voluntarily following the reduction in the severity of the behavioral disorder with the involuntary treatment. The issues involved in this form of treatment are discussed with regard to the social and health care environment in the country.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12645684     DOI: 10.1093/oxfordjournals.schbul.a006960

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  24 in total

1.  Medical diplomacy and global mental health: from community and national institutions to regional centers of excellence.

Authors:  Neil Krishan Aggarwal; Brandon A Kohrt
Journal:  Community Ment Health J       Date:  2013-08-06

2.  Families and medication use and adherence among Latinos with schizophrenia.

Authors:  Mercedes Hernandez; Concepción Barrio
Journal:  J Ment Health       Date:  2016-10-01

3.  Customising informed consent procedures for people with schizophrenia in India.

Authors:  Sudipto Chatterjee; Berit Kieselbach; Smita Naik; Shuba Kumar; Sujit John; Madhumitha Balaji; Mirja Koschorke; Hamid Dabholkar; Mathew Varghese; Vikram Patel; Graham Thornicroft; Rangaswamy Thara
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-03-04       Impact factor: 4.328

4.  Outcomes that matter: a qualitative study with persons with schizophrenia and their primary caregivers in India.

Authors:  Madhumitha Balaji; Sudipto Chatterjee; Beth Brennan; Thara Rangaswamy; Graham Thornicroft; Vikram Patel
Journal:  Asian J Psychiatr       Date:  2012-07-28

5.  The noncompliant patient in psychiatry: the case for and against covert/surreptitious medication.

Authors:  K S Latha
Journal:  Mens Sana Monogr       Date:  2010-01

6.  Covert medication: Do means justify the ends?

Authors:  T S Sathyanarayana Rao; Roy Abraham Kallilvayalil; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2012-07       Impact factor: 1.759

7.  Surreptitious practices in the management of persons with serious mental illnesses - Perspectives from the schizophrenia research foundation.

Authors:  Padmavati Ramachandran; Thara Rangaswamy
Journal:  Indian J Psychiatry       Date:  2012-07       Impact factor: 1.759

8.  On the need to have "rules" to regulate covert medication.

Authors:  James T Antony
Journal:  Indian J Psychiatry       Date:  2012-07       Impact factor: 1.759

9.  Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.

Authors:  Solomon Teferra; Charlotte Hanlon; Teferra Beyero; Lars Jacobsson; Teshome Shibre
Journal:  BMC Psychiatry       Date:  2013-06-17       Impact factor: 3.630

10.  Covert medication; the last option: A case for taking it out of the closet and using it selectively.

Authors:  A K Kala
Journal:  Indian J Psychiatry       Date:  2012-07       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.